Clinical Trial

Genetics of Neonatal Encephalopathy and Related Disorders

Recruiting
View on ClinicalTrials.gov →
Summary
Investigators at Boston Children's Hospital are conducting research in order to better understand the genetic factors which may contribute to neonatal encephalopathy (NE) and related disorders. These findings may help explain the broad spectrum of clinical features and outcomes seen in individuals with a history of NE.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-03.
Status change: Not Yet Recruiting → Recruiting 2026-03-09
Trial Details
NCT Number NCT07165938
Lead Sponsor Boston Children's Hospital
Conditions Neonatal Encephalopathy, Hypoxic Ischaemic Encephalopathy (HIE)
Enrollment 300 participants
Start Date 2026-02-04
Primary Completion 2035-09 (estimated)
Study Completion 2035-09 (estimated)
Updated on ClinicalTrials.gov 2026-03-11